Latest News

Pure Maple Syrup stars for Liver Health
Recent research revealed that Pure Maple Syrup may be beneficial to your health. According to a recent research conducted by Dr. Keiko Abe from the University of Tokyo, there might be a surprising way of keeping your liver healthy - usage of pure maple syrup in your diet. According to this study, Pure maple syrup may promote a healthy liver. Additionally, a research conducted before this one, at University of Rhode Island, found more than 20 compounds in maple syrup that have been linked to human health. So we are not talking about just liver now, but pure maple syrup can be good for the entire human body. This research was conducted by medicinal plant research specialist Navindra Seeram. So, Pure Maple Syrup is good for your liver.

Susan Lucci: AFib risks are real
Marko Stout - The NYC artist
Video: "Datenight" Tina Fey & Steve Carell
Video: Rise & Shine The Drop New Releases

Star stuff

Video: Past Box Office Races 4-13-10


Video: Wonderful Afterlife premiere
Video: "How to Train Your Dragon" America Ferrera
Video: Movie Lady Reviews 'Date Night'
Video: Vivica Fox coming to Buffalo for movie
Video: SNTV - Sneak Peek: The Losers
Video: "Death at a Funeral" Chris Rock
Entertainment
    - Movies
    - Music
    - Celebrity
World news
    - USA
    - Europe
    - Americas
    - Africa
    - Asia-Pacific
    - Middle East
    - South Asia
    - Business
    - Health
    - Science
    - Tech
Sports
    - Football
    - Soccer
    - Baseball
    - Other sports
Health News

Want to quit smoking? Try a new drug



New York, July 5 (IANS) A new drug that aids in kicking the smoking habit has been approved by the US Food and Drug Administration (FDA).

The drug Chantix (varenicline) quadruples a smoker's odds of quitting the habit, and is twice as effective as an existent smoking-cessation drug, Zyban (bupropion), reported health portal HealthDay News.

According to scientists, Chantix will also help smokers stay away from smoking months after quitting.

It greatly decreases smokers' likelihood of relapse in the first six months after quitting, said a study conducted recently.

The result is encouraging, say experts, as smokers have little that's pharmacologically useful in helping them to quit.

However, they warn that much of the hype around the new drug may be unwarranted, because Chantix remains a far-from-perfect means of quitting smoking.

Whenever a new smoking-cessation aid gets FDA approval, 'there is often unbridled enthusiasm regarding the potential to solve the problems associated with smoking,' said Robert Klesges at the University of Tennessee Health Science Center in the journal Memphis.

While Chantix does appear to perform better than either a placebo or Zyban, high rates of both side effects and treatment failure mean the drug 'definitely is not a panacea for smoking cessation,' added Klesges.

The results of these trials are promising, he said, but pointed out that nicotine addiction remains an impossibly tough challenge for most smokers.

The resilience of the smoking habit against all interventions suggests that 'patients currently cannot and probably never will be able to 'take a pill' that will make them stop smoking.'



© 2006 Indo-Asian News Service

Stararticle.com © All rights reserved